-
-
-
-
-
-
-
Corbus Pharma (CRBP) Misses Q3 EPS by 190c
-
-
-
-
-
-
-
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Corbus Pharma (CRBP) Reports Q4; Provides Corporate Updates
-
-
-
-
-
-
-
Corbus Pharmaceuticals (CRBP) PT Raised to $1.79 at Roth Capital, Following Earnings
-
-
-
-
-
-
-
Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Updates
-
-
-
-
-
-
-
Pre-Open Stock Movers 07/07: (NVAX) (VSLR) (RUN) Higher; (EOLS) (CLLS) (MARK) Lower (more...)
-
1,215,863 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

